Armistice Capital, Llc Re Shape Lifesciences Inc. (RSLS) insider trading activity
Armistice Capital, LLC is > 10% Shareholder of ReShape Lifesciences Inc.. Currently has a direct ownership of 7.22 Million shares of RSLS, which is worth approximately $40.1 Million. The most recent transaction as insider was on Jun 28, 2021, when has been sold 7,130,806 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
7.22M
0%
3M change
0%
12M change
Total Value Held
$40.1 Million
ARMISTICE CAPITAL, LLC Transaction History
Also insider at
ACL
Armistice Capital, LLC
> 10% Shareholder
New York, NY